BioNTech SE (BNTX) Assets Average (2019 - 2025)

BioNTech SE has disclosed Assets Average across 7 years of filings, most recently posting $25.3 billion for Q4 2025.

• Assets Average for Q4 2025 came in at $25.3 billion, up 3.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $25.3 billion (up 3.84% YoY), and the FY2025 annual result was $24.5 billion, changed 0.18% from the prior year.
• Assets Average came in at $25.3 billion for Q4 2025 at BioNTech SE, up from $24.7 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $25.3 billion in Q4 2025 to a low of $3.9 billion in Q1 2021.
• The 5-year median for Assets Average is $23.6 billion (2023), against an average of $21.1 billion.
• Across the five-year window, Assets Average soared 905.48% in 2021 and declined 5.26% in 2025, its largest moves.
• BioNTech SE's Assets Average stood at $17.4 billion in 2021, then jumped by 33.54% to $23.3 billion in 2022, then gained by 5.0% to $24.5 billion in 2023, then dropped by 0.51% to $24.3 billion in 2024, then gained by 3.84% to $25.3 billion in 2025.
• The last three Assets Average figures came in at $25.3 billion (Q4 2025), $24.7 billion (Q3 2025), and $23.4 billion (Q2 2025), per Business Quant data.